Surgical management of corneal perforation secondary to gonococcal keratoconjunctivitis

Eye

Volumn 23, Issue 2, 2009, Pages 339-344

  Kawashima, M ^a   Kawakita, T ^a   Den, S ^a   Tomita, M ^a   Shimazaki, J ^a,b  

^a TOKYO DENTAL COLLEGE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corneal perforation; Gonococcal keratoconjunctivitis; Keratoplasty; Neisseria gonorrhoeae

Indexed keywords

CEPHEM DERIVATIVE; OFLOXACIN; PENICILLIN G; ANTIINFECTIVE AGENT;

ADULT; ANAMNESIS; ANTERIOR EYE CHAMBER; ARTICLE; CASE STUDY; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORNEA PERFORATION; CORNEA TRANSPLANTATION; CRYOPRESERVATION; DISEASE SEVERITY; EPIDEMIC; FEMALE; FOLLOW UP; GONOCOCCAL CONJUNCTIVITIS; HUMAN; KERATOPLASTY; LABORATORY TEST; MALE; NEISSERIA GONORRHOEAE; PENETRATING KERATOPLASTY; PRESCHOOL CHILD; SEXUAL TRANSMISSION; SURGICAL APPROACH; TREATMENT OUTCOME; VISUAL ACUITY; ANTIBIOTIC RESISTANCE; COMPLICATION; CORNEA STROMA; CORNEAL PERFORATION; DRUG EFFECTS; EVALUATION STUDY; EYE INFECTIONS, BACTERIAL; GONORRHEA; KERATOCONJUNCTIVITIS; MICROBIOLOGY; PATHOLOGY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; CORNEAL PERFORATION; CORNEAL STROMA; CORNEAL TRANSPLANTATION; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; FEMALE; GONORRHEA; HUMANS; KERATOCONJUNCTIVITIS; MALE; NEISSERIA GONORRHOEAE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 60149094150     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6703051     Document Type: Article

References (26)

1. Tanaka M, Matsumoto T, Sakumoto M, Takahashi K, Saika T, Kabayashi I et al. Reduced clinical efficacy of pazufloxacin against gonorrhea due to high prevalence of quinolone-resistant isolates with the GyrA mutation. The Pazufloxacin STD Group. Antimicrob Agents Chemother 1998; 42: 579-582.
2. Tanaka M, Nakayama H, Haraoka M, Saika T. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998. J Clin Microbiol 2000; 38: 521-525.
3. Lee JS, Choi HY, Lee JE, Lee SH, Oum BS. Gonococcal keratoconjunctivitis in adults. Eye 2002; 16: 646-649.
4. Tanaka M, Nakayama H, Notomi T, Irie S, Tsunoda Y, Okadome A et al. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates. Int J Antimicrob Agents 2004; 24(Suppl 1): S15-S22.
5. Little JW. Gonorrhea: update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 137-143.
6. Ullman S, Roussel TJ, Culbertson WW, Forster RK, Alfonso E, Mendelsohn AD et al. Neisseria gonorrhoeae keratoconjunctivitis. Ophthalmology 1987; 94: 525-531.
7. Ullman S, Roussel TJ, Forster RK. Gonococcal keratoconjunctivitis. Surv Ophthalmol 1987; 32: 199-208.
8. Wan WL, Farkas GC, May WN, Robin JB. The clinical characteristics and course of adult gonococcal conjunctivitis. Am J Ophthalmol 1986; 102: 575-583.
9. The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004. Commun Dis Intell 2006; 30: 129-132.
10. Kestelyn P, Bogaerts J, Stevens AM, Piot P, Meheus A. Treatment of adult gonococcal keratoconjunctivitis with oral norfloxacin. Am J Ophthalmol 1989; 108: 516-523.
11. Matsumoto T, Muratani T, Takahashi K, Ikuyama T, Yokoo D, Ando Y et al. Multiple doses of cefodizime are necessary for the treatment of Neisseria gonorrhoeae pharyngeal infection. J Infect Chemother 2006; 12: 145-147.
12. Inoue Y. [Treatment of viral conjunctivitis]. Nippon Ganka Gakkai Zasshi 2003; 107: 24-26.
13. Takahashi S, Takeyama K, Kunishima Y, Shimizu T, Nshiyama N, Hotta H et al. Incidence of sexually transmitted diseases in Hokkaido, Japan, 1998 to 2001. J Infect Chemother 2004; 10: 163-167.
14. Ito M, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48: 3185-3187.
15. Berglund T, Asikainen T, Grutzmeier S, Ruden AK,Wretlind B, Sandstrom E. The epidemiology of gonorrhea among men who have sex with men in Stockholm, Sweden, 1990-2004. Sex Transm Dis 2007; 34: 174-179.
16. Oishi MH, Hatano H, Abe T, Sasagawa T, Abe H. A nationwide survey regarding control of infection and use of antimicrobial drugs in eye surgery. Rinsho Ganka 2003; 57: 499-502.
17. Okamoto S. Bacterial conjunctivitis. Ganka 2003; 45: 843-849.
18. Weiss JL, Williams P, Lindstrom RL, Doughman DJ. The use of tissue adhesive in corneal perforations. Ophthalmology 1983; 90: 610-615.
19. Cavanaugh TB, Gottsch JD. Infectious keratitis and cyanoacrylate adhesive. Am J Ophthalmol 1991; 111: 466-472.
20. Rodriguez-Ares MT, Tourino R, Lopez-Valladares MJ, Gude F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea 2004; 23: 577-583.
21. Hill JC. Use of penetrating keratoplasty in acute bacterial keratitis. Br J Ophthalmol 1986; 70: 502-506.
22. Claerhout I, Beele H, Van den Abeele K, Kestelyn P. Therapeutic penetrating keratoplasty: clinical outcome and evolution of endothelial cell density. Cornea 2002; 21: 637-642.
23. Nurozler AB, Salvarli S, Budak K, Onat M, Duman S. Results of therapeutic penetrating keratoplasty. Jpn J Ophthalmol 2004; 48: 368-371.
24. Shimmura S, Shimazaki J, Tsubota K. Therapeutic deep lamellar keratoplasty for cornea perforation. Am J Ophthalmol 2003; 135: 896-897.
25. Tong L, Tan DT, Abano JM, Lim L. Deep anterior lamellar keratoplasty in a patient with descemetocele following gonococcal keratitis. Am J Ophthalmol 2004; 138: 506-507.
26. Sukhija J, Jain AK. Outcome of therapeutic penetrating keratoplasty in infectious keratitis. Ophthalmic Surg Lasers Imaging 2005; 36: 303-309.